These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23678398)
1. A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase. Vlachakis D; Koumandou VL; Kossida S PeerJ; 2013; 1():e74. PubMed ID: 23678398 [TBL] [Abstract][Full Text] [Related]
2. An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets. Papageorgiou L; Loukatou S; Sofia K; Maroulis D; Vlachakis D Mol Biosyst; 2016 Jun; 12(7):2080-93. PubMed ID: 26864387 [TBL] [Abstract][Full Text] [Related]
3. Molecular modeling and pharmacophore elucidation study of the Classical Swine Fever virus helicase as a promising pharmacological target. Vlachakis D; Kossida S PeerJ; 2013; 1():e85. PubMed ID: 23781407 [TBL] [Abstract][Full Text] [Related]
4. Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI). Borowski P; Heising MV; Miranda IB; Liao CL; Choe J; Baier A Biochem Pharmacol; 2008 Jul; 76(1):28-38. PubMed ID: 18479669 [TBL] [Abstract][Full Text] [Related]
5. NS3 from Hepatitis C Virus Strain JFH-1 Is an Unusually Robust Helicase That Is Primed To Bind and Unwind Viral RNA. Zhou T; Ren X; Adams RL; Pyle AM J Virol; 2018 Jan; 92(1):. PubMed ID: 29070684 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Kim JL; Morgenstern KA; Griffith JP; Dwyer MD; Thomson JA; Murcko MA; Lin C; Caron PR Structure; 1998 Jan; 6(1):89-100. PubMed ID: 9493270 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-picornaviridae in vitro activity of a new class of helicase inhibitors the N,N'-bis[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl] alkyldicarboxamides. Carta A; Loriga M; Piras S; Paglietti G; Ferrone M; Fermeglia M; Pricl S; La Colla P; Collu G; Sanna T; Loddo R Med Chem; 2007 Nov; 3(6):520-32. PubMed ID: 18045201 [TBL] [Abstract][Full Text] [Related]
8. Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy. Borowski P; Schalinski S; Schmitz H Antiviral Res; 2002 Sep; 55(3):397-412. PubMed ID: 12206878 [TBL] [Abstract][Full Text] [Related]
9. X-ray structure of the pestivirus NS3 helicase and its conformation in solution. Tortorici MA; Duquerroy S; Kwok J; Vonrhein C; Perez J; Lamp B; Bricogne G; Rümenapf T; Vachette P; Rey FA J Virol; 2015 Apr; 89(8):4356-71. PubMed ID: 25653438 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses. Bretner M; Schalinski S; Haag A; Lang M; Schmitz H; Baier A; Behrens SE; Kulikowski T; Borowski P Antivir Chem Chemother; 2004 Jan; 15(1):35-42. PubMed ID: 15074713 [TBL] [Abstract][Full Text] [Related]
11. Structure-based mutagenesis study of hepatitis C virus NS3 helicase. Lin C; Kim JL J Virol; 1999 Oct; 73(10):8798-807. PubMed ID: 10482634 [TBL] [Abstract][Full Text] [Related]
12. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus. Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067 [TBL] [Abstract][Full Text] [Related]
13. Theoretical study of the Usutu virus helicase 3D structure, by means of computer-aided homology modelling. Vlachakis D Theor Biol Med Model; 2009 Jun; 6():9. PubMed ID: 19555498 [TBL] [Abstract][Full Text] [Related]